Literature DB >> 6328559

Reduction of the cAMP response to norepinephrine in rat cerebral cortex following repeated restraint stress.

E A Stone, J E Platt, R Trullas, A V Slucky.   

Abstract

The present studies examined the effect of restraint stress on the sensitivity of the catecholamine-cAMP generating system in the rat cerebral cortex. Restraint was found to cause a persistent reduction in the magnitude of the cAMP response to catecholamines. This effect occurred after repeated but not acute stress and was more marked with twice-daily as compared to once-daily treatment. The reduction in response was more marked with norepinephrine than with isoproterenol, indicating a selective action of stress on the non-beta component of the noradrenergic response. The findings suggest that subsensitivity of the cAMP response to norepinephrine is a general response to chronic stressful stimuli and may be related to the action of certain antidepressant agents.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6328559     DOI: 10.1007/bf00427695

Source DB:  PubMed          Journal:  Psychopharmacology (Berl)        ISSN: 0033-3158            Impact factor:   4.530


  10 in total

1.  A possible common mechanism of action of antidepressant treatments: reduction in the sensitivity of the noradrenergic cyclic AMP gererating system in the rat limbic forebrain.

Authors:  J Vetulani; R J Stawarz; J V Dingell; F Sulser
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1976-05       Impact factor: 3.000

2.  Adrenal and urinary catecholamines in rats during adaptation to repeated immobilization stress.

Authors:  R Kvetnansky; L Mikulaj
Journal:  Endocrinology       Date:  1970-10       Impact factor: 4.736

3.  Reduction by stress of norepinephrine-stimulated accumulation of cyclic AMP in rat cerebral cortex.

Authors:  E A Stone
Journal:  J Neurochem       Date:  1979-04       Impact factor: 5.372

4.  Mechanism of stress-induced subsensitivity to norepinephrine.

Authors:  E A Stone
Journal:  Pharmacol Biochem Behav       Date:  1981-05       Impact factor: 3.533

5.  Action of mianserin and zimelidine on the norepinephrine receptor coupled adenylate cyclase system in brain: subsensitivity without reduction in beta-adrenergic receptor binding.

Authors:  R Mishra; A Janowsky; F Sulser
Journal:  Neuropharmacology       Date:  1980-10       Impact factor: 5.250

6.  Brain adrenergic receptors and resistance to stress.

Authors:  E A Stone; J E Platt
Journal:  Brain Res       Date:  1982-04-15       Impact factor: 3.252

7.  Influence of adrenocorticotropin hormone and yohimbine on antidepressant-induced declines in rat brain neurotransmitter receptor binding and function.

Authors:  D A Kendall; R Duman; J Slopis; S J Enna
Journal:  J Pharmacol Exp Ther       Date:  1982-09       Impact factor: 4.030

8.  Norepinephrine stimulated cyclic AMP accumulation in rat limbic forebrain slices: partial mediation by a subpopulation of receptors with neither alpha nor beta characteristics.

Authors:  P L Mobley; F Sulser
Journal:  Eur J Pharmacol       Date:  1979-12-07       Impact factor: 4.432

9.  Cyclic AMP-generating systems: regional differences in activation by adrenergic receptors in rat brain.

Authors:  J W Daly; W Padgett; C R Creveling; D Cantacuzene; K L Kirk
Journal:  J Neurosci       Date:  1981-01       Impact factor: 6.167

10.  Norepinephrine-sensitive adenylate cyclase system in rat brain: role of adrenal corticosteroids.

Authors:  P L Mobley; D H Manier; F Sulser
Journal:  J Pharmacol Exp Ther       Date:  1983-07       Impact factor: 4.030

  10 in total
  2 in total

Review 1.  Sex-Specific Brain Transcriptional Signatures in Human MDD and Their Correlates in Mouse Models of Depression.

Authors:  Maureen Touchant; Benoit Labonté
Journal:  Front Behav Neurosci       Date:  2022-05-03       Impact factor: 3.617

2.  Previous chronic chlorimipramine treatment did not modify some physiological responses to acute and chronic stress in rats.

Authors:  A Armario; C García-Marquez; M Giralt
Journal:  Psychopharmacology (Berl)       Date:  1988       Impact factor: 4.530

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.